Qiong Zhao

Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors

Qiong Zhao, Jianzhong Shentu, Nong Xu et al. · Lung Cancer · 2010 · 98 citations

Medicine, Oncology, Pharmacology +12

Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes

Jian Liu, Yongquan Dong, Chao Lü et al. · Oncotarget · 2017 · 60 citations · Full text

Medicine, Nutritional Sciences, Oncology +17

Chimeric Antigen Receptor-Modified T Cells Redirected to EphA2 for the Immunotherapy of Non-Small Cell Lung Cancer

Ning Li, Shaohui Liu, Mingjiao Sun et al. · Translational Oncology · 2017 · 54 citations · Full text

Life Sciences, Immunology, Oncology +17

Incidence and relative risk of cutaneous squamous cell carcinoma with single-agent BRAF inhibitor and dual BRAF/MEK inhibitors in cancer patients: a meta-analysis

Ling Peng, Yina Wang, Yun Hong et al. · Oncotarget · 2017 · 51 citations · Full text

Medicine, Oncology, Pharmacology +12

China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version)

Yuankai Shi, Yan Sun, Jinming Yu et al. · Asia-Pacific Journal of Clinical Oncology · 2016 · 44 citations

Medicine, Oncology, Surgery +12